Literature DB >> 9862563

Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells.

T Danielsen1, M Hvidsten, T Stokke, K Solberg, E K Rofstad.   

Abstract

Hypoxia has been shown to induce accumulation of p53 and of hypophosphorylated retinoblastoma protein (pRb) in tumour cells. In this study, the cell cycle dependence of p53 accumulation and pRb hypophosphorylation in four human melanoma cell lines that are wild type for p53 was investigated using two-parameter flow cytometry measurements of p53 or pRb protein content and DNA content. The hypoxia-induced increase in p53 protein was higher in S-phase than in G1 and G2 phases in all cell lines. The accumulation of p53 in S-phase during hypoxia was not related to hypoxia-induced apoptosis or substantial cell cycle specific cell inactivation during the first 24 h of reoxygenation. pRb was hypophosphorylated in all cell cycle phases by hypoxia treatment. The results did not support a direct link between p53 and pRb during hypoxia because p53 was induced in a cell cycle-specific manner, whereas no cell cycle-dependent differences in pRb hypophosphorylation were detected. Only a fraction of the cell populations (0.60+/-0.10) showed hypophosphorylated pRb. Thus, pRb is probably not the only mediator of the hypoxia-induced cell cycle block seen in all cells and all cell cycle phases. Moreover, the cell cycle-dependent induction of p53 by hypoxia suggests that the primary function of p53 accumulation during hypoxia is other than to arrest the cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862563      PMCID: PMC2063247          DOI: 10.1038/bjc.1998.722

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage.

Authors:  O Amellem; E O Pettersen
Journal:  Cell Prolif       Date:  1991-03       Impact factor: 6.831

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus.

Authors:  E A Komarova; C R Zelnick; D Chin; M Zeremski; A S Gleiberman; S S Bacus; A V Gudkov
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

4.  Retention of cellular radiation sensitivity in cell and xenograft lines established from human melanoma surgical specimens.

Authors:  E K Rofstad
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

Review 5.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

6.  Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements.

Authors:  M Höckel; K Schlenger; C Knoop; P Vaupel
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

7.  The retinoblastoma gene product is bound in the nucleus in early G1 phase.

Authors:  T Stokke; B K Erikstein; L Smedshammer; E Boye; H B Steen
Journal:  Exp Cell Res       Date:  1993-01       Impact factor: 3.905

8.  Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression.

Authors:  J W Ludlow; R L Howell; H C Smith
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation.

Authors:  D J Templeton
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

Review 10.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

View more
  5 in total

1.  TCM matrine inducescell arrest and apoptosis with recovery expression of the hepato-specific miR122a in human hepatocellular carcinomaHep G2cell line.

Authors:  Wuyuan Zhou; Xiang Xu; Jie Gao; Pengfei Sun; Lei Li; Xuetao Shi; Jie Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  In vitro effects of mitomycin C on the proliferation of the non-small-cell lung cancer line A549.

Authors:  Qi An; Chao Han; Yubing Zhou; Feng Li; Duolu Li; Xiaojian Zhang; Zujiang Yu; Zhenfeng Duan; Quancheng Kan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: inactivation of ribonucleotide reductase and redox-mediated checkpoint control.

Authors:  Harish Muniyappa; Shiwei Song; Christopher K Mathews; Kumuda C Das
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

4.  Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer.

Authors:  Xueming Ying; Jun Chen; Xueming Huang; Peng Huang; Shaocong Yan
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

5.  Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 non-small cell lung cancer cell line.

Authors:  Qi An; Chao Han; Yubing Zhou; Feng Li; Duolu Li; Xiaojian Zhang; Zujiang Yu; Zhenfeng Duan; Quancheng Kan
Journal:  Mol Med Rep       Date:  2016-09-20       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.